Page last updated: 2024-08-16

pirinixic acid and ys 121

pirinixic acid has been researched along with ys 121 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
George, S; Greiner, C; Hoernig, C; Koeberle, A; Popescu, L; Schubert-Zsilavecz, M; Steinhilber, D; Syha, I; Werz, O1
Greiner, C; Koeberle, A; Schubert-Zsilavecz, M; Werz, O; Wurglics, M; Zettl, H1
Paulke, A; Proschak, E; Schneider, G; Schubert-Zsilavecz, M; Steri, R; Thieme, TM1
Dittrich, M; Lamers, C; Proschak, E; Schubert-Zsilavecz, M; Steri, R1
Gomez, RC; Hanke, T; Lamers, C; Schneider, G; Schubert-Zsilavecz, M; Werz, O1
Gabler, M; Schubert-Zsilavecz, M1

Other Studies

6 other study(ies) available for pirinixic acid and ys 121

ArticleYear
Novel and potent inhibitors of 5-lipoxygenase product synthesis based on the structure of pirinixic acid.
    Journal of medicinal chemistry, 2008, Sep-11, Volume: 51, Issue:17

    Topics: Aminoquinolines; Cells, Cultured; Esterification; Humans; Hypersensitivity; Inflammation; Leukocytes; Lipoxygenase; Lipoxygenase Inhibitors; Pyrimidines; Structure-Activity Relationship

2008
Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
    Journal of medicinal chemistry, 2008, Dec-25, Volume: 51, Issue:24

    Topics: Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Cyclooxygenase 1; Cyclooxygenase 2; Drug Design; Enzyme Activation; Enzyme Inhibitors; Humans; Inflammation; Inhibitory Concentration 50; Intramolecular Oxidoreductases; Lipoxygenase Inhibitors; Models, Chemical; Prostaglandin-E Synthases; Pyrimidines

2008
Rational design of a pirinixic acid derivative that acts as subtype-selective PPARgamma modulator.
    Bioorganic & medicinal chemistry letters, 2010, Apr-15, Volume: 20, Issue:8

    Topics: Drug Design; Models, Molecular; PPAR gamma; Pyrimidines

2010
Molecular determinants for improved activity at PPARα: structure-activity relationship of pirinixic acid derivatives, docking study and site-directed mutagenesis of PPARα.
    Bioorganic & medicinal chemistry letters, 2014, Aug-15, Volume: 24, Issue:16

    Topics: Dose-Response Relationship, Drug; Humans; Hydrogen Bonding; Molecular Docking Simulation; Molecular Structure; Mutagenesis, Site-Directed; PPAR alpha; Pyrimidines; Structure-Activity Relationship

2014
Identification of pirinixic acid derivatives bearing a 2-aminothiazole moiety combines dual PPARα/γ activation and dual 5-LO/mPGES-1 inhibition.
    Bioorganic & medicinal chemistry letters, 2014, Aug-15, Volume: 24, Issue:16

    Topics: Arachidonate 5-Lipoxygenase; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Intramolecular Oxidoreductases; Models, Molecular; Molecular Structure; PPAR alpha; PPAR gamma; Prostaglandin-E Synthases; Pyrimidines; Structure-Activity Relationship; Thiazoles

2014
Tertiary alkylamines as nucleophiles in substitution reactions at heteroaromatic halide during the synthesis of the highly potent pirinixic acid derivative 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS-121).
    Molecules (Basel, Switzerland), 2011, Dec-05, Volume: 16, Issue:12

    Topics: Amines; Hydrocarbons, Halogenated; Models, Chemical; Pyrimidines

2011